Diabetes Care, Vol 21, Issue 7 1194-1197, Copyright © 1998 by American Diabetes Association

ARTICLES

Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns

J Rissanen, L Saarinen, S Heikkinen, P Kekalainen, L Mykkanen, J Kuusisto, SS Deeb and M Laakso
Department of Medicine, University of Kuopio, Finland.

OBJECTIVE: To investigate the effect of the islet promoter region variant (G-->A) at nucleotide -30 of the glucokinase (GCK) gene on insulin levels in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and NIDDM. RESEARCH DESIGN AND METHODS: The study population included 294 subjects with NGT, 83 subjects with IGT, and 36 subjects with NIDDM. Oral glucose tolerance tests (OGTTs) were performed in all subjects, and intravenous glucose tolerance tests (IVGTTs) were performed in subjects with NGT. The islet promoter region of the GCK gene was amplified with polymerase chain reaction and screened for the variant (-30) using single-strand conformation polymorphism analysis. RESULTS: The islet promoter variant (-30) of the GCK gene was found in 17% of subjects with NGT, 23% of subjects with IGT, and 14% of patients with NIDDM (NS between the groups). Fasting, 1-h, and 2-h insulin levels, measured by OGTT, did not differ between subjects with and without this variant in any of the three groups. Furthermore, first-phase insulin secretion, determined by an IVGTT in subjects with NGT, did not associate with presence of the islet promoter region variant (-30) of the GCK gene. CONCLUSIONS: These results indicate that the variant (-30) of the islet promoter region of the GCK gene does not have a significant effect on insulin secretion in Finnish subjects with NGT, IGT, or NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Holmkvist, P. Almgren, V. Lyssenko, C. M. Lindgren, K.-F. Eriksson, B. Isomaa, T. Tuomi, P. Nilsson, and L. Groop Common Variants in Maturity-Onset Diabetes of the Young Genes and Future Risk of Type 2 Diabetes Diabetes, June 1, 2008; 57(6): 1738 - 1744. [Abstract] [Full Text] [PDF]

				W. Winckler, M. N. Weedon, R. R. Graham, S. A. McCarroll, S. Purcell, P. Almgren, T. Tuomi, D. Gaudet, K. B. Bostrom, M. Walker, et al. Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes Diabetes, March 1, 2007; 56(3): 685 - 693. [Abstract] [Full Text] [PDF]

				C. S. Rose, J. Ek, S. A. Urhammer, C. Glumer, K. Borch-Johnsen, T. Jorgensen, O. Pedersen, and T. Hansen A -30G>A Polymorphism of the {beta}-Cell-Specific Glucokinase Promoter Associates With Hyperglycemia in the General Population of Whites Diabetes, October 1, 2005; 54(10): 3026 - 3031. [Abstract] [Full Text] [PDF]

				M. N. Weedon, T. M. Frayling, B. Shields, B. Knight, T. Turner, B. S. Metcalf, L. Voss, T. J. Wilkin, A. McCarthy, Y. Ben-Shlomo, et al. Genetic Regulation of Birth Weight and Fasting Glucose by a Common Polymorphism in the Islet Cell Promoter of the Glucokinase Gene Diabetes, February 1, 2005; 54(2): 576 - 581. [Abstract] [Full Text] [PDF]

				W. Marz, M. Nauck, M. M. Hoffmann, D. Nagel, B. O. Boehm, W. Koenig, D. Rothenbacher, and B. R. Winkelmann G(-30)A Polymorphism in the Pancreatic Promoter of the Glucokinase Gene Associated With Angiographic Coronary Artery Disease and Type 2 Diabetes Mellitus Circulation, June 15, 2004; 109(23): 2844 - 2849. [Abstract] [Full Text] [PDF]

				S. C. Elbein, J. Sun, E. Scroggin, K. Teng, and S. J. Hasstedt Role of Common Sequence Variants in Insulin Secretion in Familial Type 2 Diabetic Kindreds: The sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1{alpha} genes Diabetes Care, March 1, 2001; 24(3): 472 - 478. [Abstract] [Full Text]